Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

January 5, 2020

Primary Completion Date

December 20, 2021

Study Completion Date

December 21, 2021

Conditions
Chronic Hepatitis BNonalcoholic Fatty Liver Disease
Interventions
DRUG

Chronic Hepatitis B

92 patients included in the study were randomly divided into 2 groups, 42 patients in the control group and 50 patients in the treatment group. Both groups of patients received conventional basic treatment such as liver protection. Moreover, in both groups, patients were instructed to change their dietary structure to control low-fat and low-sugar, and were instructed to perform appropriate aerobic exercise.

Trial Locations (1)

Unknown

Sichuan Leshan traditional Chinese medicine hospital, Leshan

All Listed Sponsors
lead

Sichuan Leshan Traditional Chinese Medicine Hospital

OTHER

NCT05523648 - Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD | Biotech Hunter | Biotech Hunter